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Abstract
Introduction: A central issue in the design of microarray-based analysis of global gene expression is that variability resulting
from experimental processes may obscure changes resulting from the effect being investigated. This study quantified the
variability in gene expression at each level of a typical in vitro stimulation experiment using human peripheral blood
mononuclear cells (PBMC). The primary objective was to determine the magnitude of biological and technical variability
relative to the effect being investigated, namely gene expression changes resulting from stimulation with
lipopolysaccharide (LPS).
Methods and Results: Human PBMC were stimulated in vitro with LPS, with replication at 5 levels: 5 subjects each on 2
separate days with technical replication of LPS stimulation, amplification and hybridisation. RNA from samples stimulated
with LPS and unstimulated samples were hybridised against common reference RNA on oligonucleotide microarrays. There
was a closer correlation in gene expression between replicate hybridisations (0.86–0.93) than between different subjects
(0.66–0.78). Deconstruction of the variability at each level of the experimental process showed that technical variability
(standard deviation (SD) 0.16) was greater than biological variability (SD 0.06), although both were low (SD,0.1 for all
individual components). There was variability in gene expression both at baseline and after stimulation with LPS and
proportion of cell subsets in PBMC was likely partly responsible for this. However, gene expression changes after stimulation
with LPS were much greater than the variability from any source, either individually or combined.
Conclusions: Variability in gene expression was very low and likely to improve further as technical advances are made. The
finding that stimulation with LPS has a markedly greater effect on gene expression than the degree of variability provides
confidence that microarray-based studies can be used to detect changes in gene expression of biological interest in
infectious diseases.
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Introduction
Microarrays provide a powerful tool to quantify global gene
expression. A potential limitation is that variability resulting from
experimental processes may obscure changes resulting from the
effect being investigated. If the variability is substantial or
systematic, it may be erroneously interpreted as a genuine
difference. To date, there have been few studies quantifying the
variability and reproducibility of microarray experiments in
humans.
Sources of variability include biological (between subjects) and
technical (everything downstream from obtaining an RNA sample)
[1]. One study in humans assessing biological variability found
gene expression was influenced by a variety of factors including
age, sex, time of day of sampling and constituent cell subsets [2].
Further, there have been found to be familial similarities in
variability in baseline gene expression [3,4]. Technical variability
could result from any of the multiple steps involved in the
detection of gene expression changes using microarrays including
amplification of RNA and hybridisation [5]. Previous in vitro
microarray studies in tissue and cell lines to investigate whether
technical or biological variability is greater have found inconsistent
results. For example, one study investigating variance in gene
expression in lymphoblastoid cells, found that for the majority of
genes variance between individuals (biological) was greater than
variance between replicates (technical) [3]. In another study there
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19556was a low degree of technical variability when comparing two
samples of identical RNA prepared from a cell culture, but the
results were not markedly different when different cell culture
preparations were used, suggesting that the majority of the
variability was technical [1]. A separate arm of the study showed
that in some cases different cell lines from the same individual had
higher variability than the same cell lines from different
individuals. Different subjects, cell lines and technical steps were
not all compared directly with each other and the component
sources of variability from each step of the process were not
deconstructed. The authors suggested that inter-individual differ-
ences might mask changes due to a stimulus.
The aim of this study was to investigate the variability in gene
expression in an in vitro stimulation experiment using human
peripheral blood mononuclear cells (PBMC). The primary
objective was to determine the magnitude of biological and
technical variability relative to the effect being investigated,
namely gene expression changes resulting from stimulation with
lipopolysaccharide (LPS). We aimed to identify the relative
contribution of different sources of variability at each stage of
the experiment culminating in hybridisation to a microarray slide.
The results were intended to determine to what extent detected
gene expression differences in an in vitro microarray experiment in
humans can be attributed to the stimulus investigated rather than
artefactual differences from technical and biological variation.
Results
An in vitro stimulation experiment was undertaken with
replication at 5 levels (subject, day, stimulation tube, amplification
and hybridisation) (figure 1). Five subjects each had blood taken on
2 days and their peripheral blood mononuclear cells (PBMC) were
separated and stimulated with LPS in 2 parallel tubes for 24 hours
or left unstimulated. All samples were amplified and RNA was
hybridised against common reference RNA from pooled unsti-
mulated samples from all subjects. Replication was also included at
the amplification and hybridisation steps. Differences in gene
expression with LPS stimulation were measured by comparing the
log2 ratio of the stimulated samples with the unstimulated samples.
Variability in gene expression was compared between all samples
at baseline and after LPS stimulation.
Cumulative effects of variability at different levels
The hierarchy of levels of variability which underlie the
experimental design are shown by comparing gene expression
for the 2 subjects (A and B) who had replication at every level of
the experiment (figure 2). Comparisons were made between gene
expression (against the common reference) from one hybridisation
and gene expression from hybridisations at each different level of
replication. For replication at the subject level, one of the other
subjects on the same day was randomly selected for comparison.
In general, for both subjects, hybridisations correlated more
closely the further down the experimental process the replication
occurred; for example, replication by hybridising the same RNA
(Hyb2) had a correlation coefficient of 0.86–0.93, while hybrid-
ising RNA from 2 different subjects (Subject2) had a correlation of
0.66–0.78. This is because the variance is additive; for example,
the variance (s
2) at the level of amplification is a combination
(s
2
Amp+s
2
Hyb) of the variability due to amplification (s
2
Amp) and
the variability due to hybridisation (s
2
Hyb).
Multi-level random effects
To deconstruct this and to determine how much variability
there was at each level of the experiment including the LPS
interaction with subject and day (‘Subject:LPS’ and ‘Day:LPS’), a
multi-level mixed model analysis was undertaken, incorporating
both fixed and random effects (table 1) [6].
The variance at each level was in principle estimated by
subtracting the variance of the layers below it. Thus in the
example above, by subtracting the variance at the level of
hybridisation (s
2
Hyb) from the combined variance at the level of
amplification (s
2
Amp+s
2
Hyb), the variability due to amplification
alone (s
2
Amp) can be estimated.
The median standard deviation (SD, s) for all of the variance
components was very small, at less than 0.1 for all components,
and 0 for the majority (figure 3a). Note that ‘Residual’ refers to the
variance component attributable to hybridisation, but also
includes any other factors contributing to variability downstream
Figure 1. Experimental design showing samples used to compare variability. Samples: Subject A–E, Day 1 and 2, LPS-stimulated sample
(Stim) 1 and 2, amplification run (Amp) 1–3, and hybridisation (Hyb) 1–3. For each subject on each day there was also an unstimulated (Unstim)
sample at 0 hours.
doi:10.1371/journal.pone.0019556.g001
Variability in Microarrays
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amplification and hybridisation, but even these were small. The
proportion that each component contributed to the overall
variance indicated that the greatest proportion of variance was
contributed by Residual/Hybridisation, which was double that
contributed by Amplification, and nearly four times that
contributed by most of the remaining components (figure 3b).
Although the variance between different days was slightly smaller
than between different subjects, when the LPS interaction was
taken into account, the interaction between Day and LPS
contributed variability greater than the Subject or Subject:LPS
interaction.
A comparison was made between biological and technical
variability by summing the Subject and Day components for
biological variability, and the Stimulation, Amplification and
Residual components for technical variability (figure 4). Technical
variability (SD 0.16) was slightly greater than biological variability
(SD 0.06), although they were both low with the upper
interquartile range of the standard deviation for each being less
than 0.4.
Comparing combined biological and technical variance also
shows that the variance did not greatly increase when adding
different variance components together. Although the components
contributing to the variability are additive, the same genes were
not highly variable at each level, so the overall variability was not
markedly higher.
LPS response between individuals
The LPS effect is the difference between stimulated and
unstimulated samples. Overall the inter-subject variability in
response to LPS was very low with the median standard deviation
Figure 2. Matrix of scatterplots showing log2 ratios for replicate hybridisations at each level of the experiment. The fold changes for
each sample are plotted against those for each of the other samples for gene expression after stimulation with LPS for two subjects: subject A (top
right of diagonal) and subject B (bottom left). Comparisons are made at different levels of the experiment: hybridisation (Hyb2), amplification (Amp2),
stimulation (Stim2), day (Day2) and subject (Subject2). Correlation coefficients between each pair of samples are shown in the bottom right of each
box.
doi:10.1371/journal.pone.0019556.g002
Table 1. Different components contributing to variability in
the design of the study.
Component Variability Effect
Sex Biological Fixed
Subject Biological Random
Day Biological Random
LPS treatment Physiological Fixed
Stimulation tube Technical Random
Amplification Technical Random
Hybridisation Technical Random
doi:10.1371/journal.pone.0019556.t001
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consistent expression, there were a few genes that varied between
subjects in response to LPS. Genes were ranked by their
Subject:LPS variance component, and the top 10 genes that were
most variable between subjects in terms of their response to LPS
are shown in table 2.
The majority of these genes are recognisable as being involved
in the immune response, with a variety of cytokines and receptors
represented. This is consistent with previous findings of differences
in in vitro cytokine responses to stimulation with LPS between
individuals [7,8]. Potential causes of this subset of genes showing
variable response to LPS between subjects were further investi-
gated. Baseline gene expression in peripheral blood from human
subjects has previously been found to be affected by age, sex, time
of day of sampling and constituent cell subsets [2]. In animals the
response to LPS is also affected by age and sex [9]. In this study
the subjects had a narrow age range and blood was taken at the
same time each day so these variables were excluded, and the
effect of sex and constituent cell subsets was further analysed.
Effect of sex on LPS response
There is almost no overlap between genes that respond to LPS
and genes that are expressed differently between the sexes
(figure 5). The genes most differentially expressed between the
sexes were XIST (represented by 2 spots on the microarray) and
DOM3Z (figure 5). XIST is a gene expressed only on the
inactivated X chromosome, therefore only in females [10].
DOM3Z is a gene found in the MHC III region paired with
RP1, a protein thought to be involved in androgen-responsiveness
in male mice [11] which could explain its sex effect. However, the
effect of LPS on their expression was minimal. Although not
designed to investigate the effects of sex on LPS response, further
analysis showed that this effect was not strong in this study.
Effect of different days and cell subset proportions
Although the median standard deviation for both was zero, the
variability in response to LPS between days was unexpectedly
greater than between subjects (figure 3b). All hybridisations were
with the common reference RNA: from unstimulated PBMC from
subjects A–D on Day 2. There was therefore less differential
expression between the Day 2 samples and the common reference
than between the Day 1 samples and the common reference. This
suggests the finding is at least in part due to artefact.
The prime effector cells following LPS stimulation are
monocytes (CD14+), and there were differences in the proportion
of monocytes in PBMC samples from each subject on each day
(table 3). The greatest difference in proportion of monocytes
between the two days was 4.8% at 0 hours (subject B) and 7.5% at
24 hours (subject D). This difference in cell subset proportions
may partly explain the difference between Day 1 and Day 2.
However, the day-to-day variability in monocyte percentages is
less than that between subjects, so monocyte percentage alone
Figure 3. Variability of gene expression for each component level of the experiment. a) Standard deviation of all genes for each variance
component, showing median standard deviation, interquartile ranges and outliers; b) Proportion of variance contributed by each component to the
overall variance. Amp - amplification run.
doi:10.1371/journal.pone.0019556.g003
Figure 4. Standard deviation of all genes for biological and
technical variance, showing median standard deviation, inter-
quartile ranges and outliers.
doi:10.1371/journal.pone.0019556.g004
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component.
There was a wide range of monocyte proportions in PBMC
between subjects at 0 and 24 hours and some of the most variable
genes are known to be strongly expressed in monocytes, for
example, MMP1, CD163, MARCO and IL-24 [12,13,14]. There
were also genes amongst the most variable known to be expressed
in other leukocytes, for example IFNG (T cells) [15] and GZMB
(cytotoxic T cells) [16]. Although they were not measured, these
cell subset proportions also likely differed between subjects.
Variability compared to biological effect
When comparing LPS-stimulated to unstimulated samples,
4552 genes were significantly differentially expressed. A compar-
ison of the fold changes after LPS stimulation with the variability
expressed as a standard deviation on the same scale shows gene
expression in response to LPS dwarfs biological or technical
variability (figure 6).
Discussion
Technical variability is inherent in all microarray experiments
as a result of the number of elements being measured and the
number of steps in the process that culminates in hybridisation of
RNA to a microarray slide. Different methods have been used to
attempt to control the variability in microarray experiments,
including the use of control housekeeping genes on the array [17],
pre-processing and normalisation of data [18,19,20] and replica-
tion [21] which allows an estimation of error. In recent studies,
variability has even been exploited to enhance microarray data
analysis [22] and calculate sample size [23]. For these experimen-
tal and bioinformatic methods to be relevant to biology, an
understanding of the sources and magnitude of variability in gene
expression is crucial.
This is the first study to deconstruct the variability in a
microarray experiment into each level of the experimental process.
All sources of variability in this study were low. Even the largest
source of variability, the residual component measured by
replicate hybridisations, had a standard deviation of about 0.1
on the log2 scale, corresponding to 7% of gene expression level.
The low variability was partly a result of using high quality
normalization and pre-processing. Less attention to issues such as
background correction would have resulted in higher variability
[18]. However, large scale filtering of spots on quality grounds was
not undertaken, and filtering was used only to remove transcripts
not expressed in peripheral blood.
Table 2. The top 10 most variable genes between subjects by stimulation with LPS and the standard deviation (SD) of each.
Accession no. Gene name Gene symbol SD
NM_002421 Matrix metalloproteinase 1 MMP1 1.16
NM_006770 Macrophage receptor with collagenous structure MARCO 0.85
NM_001925 Defensin, alpha 4, corticostatin DEFA4 0.80
NM_004131 Granzyme B GZMB 0.68
X62468 Interferon gamma IFNG 0.67
NM_000963 Prostaglandin-endoperoxide synthase 2 PTGS2 0.67
NM_002964 S100 calcium-binding protein A8 S100A8 0.65
NM_004244 CD163 antigen CD163 0.64
NM_006850 Interleukin 24 IL24 0.62
NM_007115 Tumor necrosis factor, alpha-induced protein 6 TNFAIP6 0.59
doi:10.1371/journal.pone.0019556.t002
Figure 5. Effect of LPS and sex on gene expression with log2
ratios contributed by each component along the x and y axes
respectively.
doi:10.1371/journal.pone.0019556.g005
Table 3. Proportion of monocytes (CD14+) in different
samples.
CD14+ cells (%)
Subject 0h 2 4h
Day 1 Day 2 Day 1 Day 2
A 7.7 7.1 6.4 6.2
B 2.3 7.1 3.5 3.2
C 5.9 8.4 8.2 11.0
D 11.9 14.6 7.0 14.5
E 1.8 2.8 1.1 1.6
doi:10.1371/journal.pone.0019556.t003
Variability in Microarrays
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expression in peripheral blood is consistent with other human
gene expression studies. Whitney et al showed low variability in
baseline gene expression [2]. Our study confirmed this and
additionally is the first to show that there is low variability in
response to LPS stimulation. The response to LPS is known to be
highly conserved, even between species [24], and it is possible that
there would be more variability in gene expression in response to a
different stimulant where the response was less stereotypical.
Differences between subjects in response to LPS related largely to
genes involved in the immune response, which may explain why
individuals have different clinical responses to the same organism
and why some individuals have poor outcomes with sepsis. In
animals, sex, pregnancy, age and stress have all been shown to
affect the response to LPS [9,25,26]. A key finding was that the
differential expression induced by LPS was markedly greater than
any differences resulting from technical or biological variability.
This was true of each of the deconstructed components
contributing to variability, and when individual sources were
combined.
The largest sources of variability in this experiment were the
technical steps of amplification and hybridisation. These steps can
potentially be improved by technological developments as been
showed by comparisons between different platforms [27].
Day to day variability was comparable to or greater than
variation between subjects. The most likely explanation was that
the finding was an artefact due to the composition of the RNA
contributing to the common reference. As long as it is common to
all hybridisations, the composition of the reference RNA has
previously been thought not to matter. However, because the
differential expression was not identically distributed between
Days 1 and 2 compared to the common reference, Day 2 had a
much smaller variance. Comparison of Day 1 and Day 2 was
therefore not random, and this likely created the artefact of there
appearing to be a larger difference between days than subjects.
However, while this finding may be partly artefactual, it is also
consistent with the findings that samples from subjects who
contributed blood on multiple days do not necessarily cluster
together [2]. Factors such as how much sleep each subject got the
night before, what they had for breakfast and whether they cycled
or drove to work could all potentially affect gene expression
responses [28,29,30]. This highlights the similarity between
subjects in gene expression, both at baseline, and in response to
LPS. This suggests that blood samples collected over multiple days
may be preferable when investigating individual responses.
This study is the first to correlate variability with cell subset
proportions before and after stimulation with LPS. Monocytes
account for the largest proportion of cells in PBMC that respond
to LPS. Genes not expressed in non-monocyte cells in response to
LPS are likely to show a lower fold change overall in PBMC
samples with smaller proportions of monocytes [31]. Hence
monocyte proportion is likely to be a factor in variation, and
measuring expression in purified cell populations may reduce
variability further. However, the inter-subject variability was very
low in this study so differences in cell subset proportions did not
have a strong effect.
The microarray quality control (MAQC) project [32] was
designed to investigate variability in microarray experiments, but
differs from this study in that its aim was to assess the quality of
microarray technologies and therefore only investigated technical
replication by hybridizing identical RNA samples. It did not aim
to investigate biological replication and did not attempt to
deconstruct the components of technical variation. Therefore,
the results of this study are complementary to the MAQC project
rather than being directly comparable to it.
In summary, we found that the variability attributable to
technical and biological variation in a typical in vitro microarray
experiment in humans is low, and markedly less than the effect on
gene expression of stimulation. This provides confidence that
microarray-based studies can be used to detect changes in gene
expression of biological interest in infectious diseases.
Methods
Ethics statement
This study received approval from the Human Research Ethics
Committee (23096A) at the Royal Children’s Hospital, and
informed consent was obtained verbally from the adult volunteers.
PBMC separation and stimulation
Five adult volunteers (two female and three male, age range 21–
34 years) had blood sampled on the same two days, one week
apart, between 9 and 10 am (figure 3). Blood was collected into
tubes containing endotoxin-free lithium heparin (Becton Dick-
inson, Franklin Lakes, NJ, USA). PBMC were separated by Ficoll-
Hypaque gradient (Amersham Biosciences, Uppsala, Sweden).
Aliquots of 2610
6 PBMC were simultaneously stimulated with
1 mg/ml LPS (Sigma Aldrich, Sydney, NSW, Australia) and
incubated at 37uC with 5% CO2 for 0 and 24 hours. Each
stimulation condition was undertaken in duplicate to enable
comparison between two parallel stimulations of PBMC. At each
time point, after centrifugation, TRIzolH (Invitrogen Life Tech-
nologies, Invitrogen Corporation, Carlsbad, CA, USA) was added
to the sample before storing at 280uC. In addition, four samples
Figure 6. Standard deviations of the different variability
components and gene expression values after LPS stimulation
on the same log2 scale, showing median standard deviation,
interquartile ranges and outliers.
doi:10.1371/journal.pone.0019556.g006
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day.
RNA preparation
RNA from all samples was extracted using the chloroform:phe-
nol method within one month after stimulation before further
storage at 280uC. Samples were then purified using the
RNeasy
TM kit (Qiagen Pty Ltd, Clifton Hill, VIC, Australia) and
amplified using the MessageAmp
TM II aRNA Kit (Ambion Inc,
Austin, TX, USA) following the manufacturers’ protocols. All
samples were analysed post-amplification using an Agilent 2100
Bioanalyser (Agilent Technologies, Forest Hill, VIC, Australia). All
RNA samples were of satisfactory quality.
Cell population analysis by flow cytometry
For each subject on each day at each time point, 5610
5 PBMC
were stained with PE-conjugated CD14 (IOTestH, Immunotech,
Marseille, France) and 5610
5 cells were stained with PE-
conjugated mouse IgG1 as a negative isotype control Cells were
incubated in phosphate buffered saline (PBS), 0.1% sodium azide
and 20 ml of the conjugated antibody at room temperature for
15 min, washed and resuspended in 300 ml PBS with 2% formalin.
Analysis was undertaken using a LSR II flow cytometer and BD
FACSDivaH software (Becton Dickinson).
Microarray hybridisation
The study used 36 spotted microarrays printed with the
Compugen human 19,000 oligonucleotide library (http://www.
cgen.com) and a selection of control probes at the Adelaide
Microarray Facility (Adelaide, Australia). To minimize variability,
all microarrays were from the same printing batch, except 2 slides
(Hyb3 from subjects A and B). There were negligible differences
between slides from the different batches. Amplified RNA (aRNA)
was labelled by a direct platinum-based labelling technique using a
kit (ULS
TM aRNA labelling, Kreatech Biotechnology, Amster-
dam, The Netherlands) following the manufacturer’s protocol.
Each sample of experimental RNA (unstimulated and from each
stimulation) was competitively hybridised with a common
reference sample, obtained from pooling unstimulated RNA from
subjects A–D from Day 2. For each pair of RNA samples to be
hybridised to a slide, 2 mg of the pooled reference RNA was
labelled with ULS
TM-Cy3 and 2 mg of the individual sample RNA
with ULS
TM-Cy5. The samples amplified on a different day were
also hybridised against the pooled RNA.
In addition, three hybridisations were undertaken using the
same sample of RNA. This was done with two samples of RNA to
provide replication. The two dye-coupled samples for each array
were combined and fragmented using 4 ml Fragmentation
Reagents (Ambion). The labelled sample was mixed with 10 ml
1 mg/ml human Cot-1 DNA (Invitrogen), 15 ml2 0 6SSC, 20 ml
deionised formamide (Sigma Aldrich), 20 ml Kreatech solution
(Kreatech Biotechnology) and 5 ml 10% SDS, heated at 95uC for
5 min and cooled to room temperature. Each sample was applied
to a slide which was incubated in a water bath in the dark at 42uC
for 18 hours, washed and scanned using a GenepixH 4000B
scanner (Molecular Devices, Sunnyvale, CA, USA).
Microarray data normalisation and analysis
Each scanned TIF image was quantified using Genepix Pro 6.0
software (Molecular Devices) to obtain foreground and back-
ground intensity values for each spot. Genepix was configured to
generate the custom morphological close-open background
estimator, which is less variable than the more usual local
background estimators [33]. Pre-processing and quality assessment
was done using the limma software package [34] for the R/
Bioconductor programming environment (http://www.biocon
ductor.org). A small offset of 50 was added to the intensities after
background correction to ensure that there were no negative
background-corrected intensities or missing log-ratios, and to
ensure that low-intensity log-ratios remained of low variability.
Microarray data quality was checked using diagnostic image plots,
MA-plots and control probes and was found to be satisfactory.
Low-intensity probes were filtered on the basis of mean A-values,
which give the average log2 intensity for each probe across all
arrays. Log-ratios were print-tip loess normalised with span=0.4,
giving zero weight to probes with mean A-value,6.5 [19]. After
normalization, control probes were removed from the data leaving
only the Compugen library probes. To remove probes corre-
sponding to transcripts not expressed in PBMCs, 33% of library
probes with lowest mean A-values were filtered before subsequent
analysis.
A linear model approach was used to analyse all the microarrays
for the five individuals together. A multi-level mixed linear model
was fitted to the normalized log-ratio expression data for each
probe using the lmer() function in lme4 package for R [6]. The
multi-level variance components were estimated by restricted
maximum likelihood (REML) and the fixed effects were estimated
by generalised least squares. The principle underlying the
estimation of variance at each level of the experiment (by
maximizing the REML likelihood) was the subtraction of the
variance at each level below it. For example, the variability (s
2)
between technical replication at the level of amplification is the
sum of the variability at the level of amplification and the
variability at the level of hybridisation (s
2
Amp+s
2
Hyb). Therefore
by determining the variability introduced at the lowest level,
hybridisation (s
2
Hyb), the variability introduced at the level of
amplification can be calculated ((s
2
Amp+s
2
Hyb)2(s
2
Hyb)=s
2
Amp).
Similar calculations provide the variability at each level higher.
The mixed linear model included fixed effects for sex and LPS
treatment, and random effects for each level of variability in the
experimental design (figure 1, table 1). The model can be
represented by the formula:
M~SexzLPS treatmentzSubjectzSubject:
LPSzDayzDay:LPSzStimulation tubez
AmplificationzResidual
where M is the log2 expression value of a gene from an
individual microarray slide. The mixed model analysis decon-
structed the overall variability into the variability attributable to
each of the different components. ‘Subject:LPS’ and ‘Day:LPS’
refer to the interaction between the fixed effect of stimulation
with LPS and the variables of subject and day respectively (see
section on LPS effect). ‘Residual’ is the variance component
attributable to hybridisation, but also includes any other factors
contributing to variability downstream of amplification.
To determine the variability with LPS stimulation, the
interaction between LPS and different subjects and different days
(designated Subject:LPS and Day:LPS respectively) was included
in the model. The variance of MLPS was determined by adding the
measurement error or variance (s
2) for each of the variance
components including the Residual component:
J^var (MLPS)~s2
Subject:LPSzs2
Day:LPSzs2
Stimzs2
Ampzs2
Residual
Variability in Microarrays
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mapped to gene symbols using SOURCE [35] and the UniGene
build of 2nd September 2006. The study is MIAME compliant.
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